News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
New HER2 Targeted Therapy Alert! – Amol Akhade
Amol Akhade/LinkedIn
Apr 30, 2025, 12:46

New HER2 Targeted Therapy Alert! – Amol Akhade

Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared on X:

“New HER2 Targeted Therapy Alert!

Zongertinib (BI 1810631) = Game-changer?
• 71% ORR
• 12.4 mo PFS
• Active in brain metastases
• No ILD
• EGFR-sparing ➔ Less rash, diarrhea!

Direct comparison vs trastuzumab deruxtecan!
Clinical MoA snapshot included!”

Read Also: New Paper Alert: Zongertinib in Previously Treated HER2-Mutant NSCLC. Beamion LUNG-1 Study Results

Amol Akhade cancer OncoDaily Oncology Zongertinib
Special Coverage
Blog
Apr 30, 2025, 12:47
Tracey O'Brien: The Cancer Institute NSW's partnership with Pink Sari to support people with cancer
Science
Apr 30, 2025, 12:46
New HER2 Targeted Therapy Alert! - Amol Akhade
Science
Apr 30, 2025, 12:36
Nathan Pennell: Not beating around the bush here
Career
Apr 30, 2025, 12:33
Congratulations to Daniel D. Von Hoff on Being Recognized at the AACR Research Partners in Progress Reception - City of Hope
Blog
Apr 30, 2025, 12:10
David Fajgenbaum: Hope Should Inspire Action and Hope Cannot Be Passive
Blog
Apr 30, 2025, 11:45
ISMRC 2025: Christoffer Gebhardt to Present on ctDNA and Immunotherapy in Melanoma
Blog
Apr 30, 2025, 11:41
Read Dr Hussain Abdulla's Insights and Explore ESO Clinical Training Centres Fellowship Programme's Opportunities - ESO
Blog
Apr 30, 2025, 11:20
Sylvain Delaunay: Exciting Postdoctoral Researcher opportunity at Cancer Research UK Manchester Institute
Blog
Apr 30, 2025, 11:15
Istvan Petak: The vision of AACR - "cancer research saves lives"
Science
Apr 30, 2025, 11:05
Michael Lemma: Our paper on the very unique psychosocial support group in Eastern Ethiopia has been published
Blog
Apr 30, 2025, 11:02
Sitna Ali Mwanzi Highlights Cancer Patient Navigation Work in Kenya
Blog
Apr 30, 2025, 10:53
Amol Akhade: Aumolertinib and Chemotherapy, A New Challenger to Osimertinib?